Onconetix Inc (ONCO)

Currency in USD
2.9600
+0.1200(+4.23%)
Closed·
2.9599-0.0001(0.00%)
·
ONCO Scorecard
Full Analysis
Operates with a significant debt burden
Earnings results expected today
ONCO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.77002.9800
52 wk Range
2.6100656.8800
Key Statistics
Prev. Close
2.96
Open
2.86
Day's Range
2.77-2.98
52 wk Range
2.61-656.88
Volume
70.88K
Average Volume (3m)
807.99K
1-Year Change
-99.34%
Book Value / Share
23.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONCO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Onconetix Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Onconetix Inc Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

Employees
5

Onconetix Inc Earnings Call Summary for Q4/2024

  • Q4 2024 European sales up 35% from Q3; full-year 2024 sales reached SEK 31.6 million, nearly tripling 2023's SEK 10.9 million
  • Expanding market presence in key European countries; exploring new markets in Japan and South Korea for additional revenue streams
  • Targeting cash flow positivity by end of 2026; cash position at SEK 179 million with increased operating expenses of SEK 390 million
  • Anticipates first sales in Italy during H1 2025; CEO optimistic about company's future despite current stock volatility near 52-week low
Last Updated: 27/02/2025, 10:16
Read Full Transcript

Compare ONCO to Peers and Sector

Metrics to compare
ONCO
Peers
Sector
Relationship
P/E Ratio
0.0x−1.6x−0.5x
PEG Ratio
-−0.030.00
Price/Book
0.4x1.0x2.6x
Price / LTM Sales
0.8x16.8x3.3x
Upside (Analyst Target)
-303.0%41.6%
Fair Value Upside
Unlock22.5%5.9%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-45.44 / --
Revenue / Forecast
101.63K / --
EPS Revisions
Last 90 days

ONCO Income Statement

People Also Watch

1.660
VOR
-16.58%
5.25
REPL
+5.21%
18.80
SRPT
+4.79%
2.42
INMB
+0.83%

FAQ

What Stock Exchange Does Onconetix Trade On?

Onconetix is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Onconetix?

The stock symbol for Onconetix is "ONCO."

What Is the Onconetix Market Cap?

As of today, Onconetix market cap is 1.54M.

What Is Onconetix's Earnings Per Share (TTM)?

The Onconetix EPS (TTM) is -683.39.

When Is the Next Onconetix Earnings Date?

Onconetix will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is ONCO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Onconetix Stock Split?

Onconetix has split 2 times.

How Many Employees Does Onconetix Have?

Onconetix has 5 employees.

What is the current trading status of Onconetix (ONCO)?

As of 13 Aug 2025, Onconetix (ONCO) is trading at a price of 2.96, with a previous close of 2.96. The stock has fluctuated within a day range of 2.77 to 2.98, while its 52-week range spans from 2.61 to 656.88.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.